{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:52:08Z","timestamp":1793793128605,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010024","name":"Hungarian Science Foundation","doi-asserted-by":"publisher","award":["OTKA: FK_17-124571"],"award-info":[{"award-number":["OTKA: FK_17-124571"]}],"id":[{"id":"10.13039\/501100010024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU"},{"name":"European Regional Development"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijpharm.2019.01.024","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T12:10:38Z","timestamp":1547813438000},"page":"396-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Controlled release of methotrexate from functionalized silica-gelatin aerogel microparticles applied against tumor cell growth"],"prefix":"10.1016","volume":"558","author":[{"given":"G\u00e1bor","family":"Nagy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Kir\u00e1ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Veres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"L\u00e1z\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"F\u00e1bi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1sp\u00e1r","family":"B\u00e1nfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Kalm\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2019.01.024_b0005","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/bjc.1992.178","article-title":"Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines","volume":"65","author":"Affleck","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0010","first-page":"27","article-title":"Silica directly induces intercellular adhesion molecule 1 (ICAM-1) expression in cultured endothelial cells","volume":"7","author":"Anderegg","year":"1997","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I","article-title":"The clinical pharmacology of methotrexate: new applications of an old drug","volume":"41","author":"Bleyer","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00043426-199711000-00008","article-title":"Accumulation of methotrexate in systemic tissues after intrathecal administration","volume":"19","author":"Bleyer","year":"1997","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0025","first-page":"1025","article-title":"Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate","volume":"67","author":"Bodner","year":"1981","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5728(87)90029-4","article-title":"Antigen-targeted liposome-encapsulated methotrexate specifically kills lymphocytes sensitized to the nonapeptide of myelin basic protein","volume":"17","author":"Boggs","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00685904","article-title":"An extended-release formulation of methotrexate for subcutaneous administration","volume":"33","author":"Bonetti","year":"1994","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3835(99)00334-1","article-title":"Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate","volume":"148","author":"Boratynski","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1023\/A:1026460023503","article-title":"Characterization and in vitro methotrexate release from methotrexate\/gelatin conjugates of opposite conjugate bond polarity","volume":"17","author":"Bowman","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0050","first-page":"6359","article-title":"Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo","volume":"49","author":"Bremnes","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jps.2600830333","article-title":"Sustained-release methotrexate for intracavitary chemotherapy","volume":"83","author":"Chatelut","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ccr.2018.01.007","article-title":"Emerging nanomaterials with advanced drug delivery functions; focused on methotrexate delivery","volume":"359","author":"Choi","year":"2018","journal-title":"Coordin. Chem. Rev."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/bjc.1973.190","article-title":"Methotrexate in liver and bile after intravenous dosage in man","volume":"28","author":"Creaven","year":"1973","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/bc00032a008","article-title":"Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems","volume":"6","author":"Devineni","year":"1995","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0075","first-page":"1076","article-title":"In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody","volume":"47","author":"Endo","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0080","first-page":"399","article-title":"Growth pattern of the human promyelocytic leukaemia cell line HL60","volume":"15","author":"Foa","year":"1982","journal-title":"Cell Tissue Kinet."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tox.2009.11.010","article-title":"Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats","volume":"267","author":"Fuksa","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0162-3109(00)00189-2","article-title":"Mechanisms of action of methotrexate","volume":"47","author":"Genestier","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00003088-200342020-00003","article-title":"Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases","volume":"42","author":"Grim","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-8140(96)01728-8","article-title":"Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo-in vitro excision assay","volume":"39","author":"Hansen","year":"1996","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10495-005-2947-z","article-title":"Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production","volume":"10","author":"Huang","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/bc00019a004","article-title":"Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates","volume":"4","author":"Hudecz","year":"1993","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0115","first-page":"341","article-title":"Accumulation of methotrexate in human tissues following high-dose methotrexate therapy","volume":"48","author":"Iqbal","year":"1998","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/1523-1747.ep12612745","article-title":"Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate","volume":"104","author":"Jeffes","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000239454","article-title":"Assessment of micronucleus induction in murine SCCVII cells treated with various anticancer agents","volume":"42","author":"Jeremic","year":"1996","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1517\/17425247.2012.642362","article-title":"Methotrexate: a detailed review on drug delivery and clinical aspects","volume":"9","author":"Khan","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10495-016-1316-4","article-title":"Micronucleus formation during chromatin condensation and under apoptotic conditions","volume":"22","author":"Kiraly","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(00)00476-2","article-title":"Characterization and in vitro release of methotrexate from gelatin\/methotrexate conjugates formed using different preparation variables","volume":"204","author":"Kosasih","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/gels2040026","article-title":"A continuous extraction and pumpless supercritical CO2 drying system for laboratory-scale aerogel production","volume":"2","author":"Lazar","year":"2016","journal-title":"Gels"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mee.2013.02.021","article-title":"Sterilization on dextran-coated iron oxide nanoparticles: effects of autoclaving, filtration, UV irradiation, and ethanol treatment","volume":"111","author":"Li","year":"2013","journal-title":"Microelectron. Eng."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-5173(01)00847-X","article-title":"Biotinylated methotrexate loaded erythrocytes for enhanced liver uptake. \u2018A study on the rat\u2019","volume":"231","author":"Mishra","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-405914-6.00007-X","article-title":"Optimization of cell cycle measurement by time-lapse microscopy","author":"Nagy","year":"2012","journal-title":"Methods Cell Biol. Elsevier"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0170","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1089\/dna.2013.2147","article-title":"Cell trivision of hyperploid cells","volume":"32","author":"Nagy","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0175","series-title":"Cell Cycle Synchronization: Methods and Protocols","first-page":"161","article-title":"Chemically induced cell cycle arrest in perfusion cell culture","author":"Nagy","year":"2017"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0378-5173(93)90393-T","article-title":"Preparation, characterization and in-vitro stability of hydrophilic gelatin microspheres using a gelatin-methotrexate conjugate","volume":"95","author":"Narayani","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0378-5173(95)04323-3","article-title":"Biodegradable microspheres using two different gelatin drug conjugates for the controlled delivery of methotrexate","volume":"128","author":"Narayani","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-5173(96)04685-6","article-title":"Gelatin microsphere cocktails of different sizes for the controlled release of anticancer drugs","volume":"143","author":"Narayani","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0169-409X(01)00233-2","article-title":"The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors","volume":"53","author":"Needham","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0005-2736(88)90400-2","article-title":"Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-\u03b3-dimyristoylphosphatidylethanolamine","volume":"946","author":"No\u00e9","year":"1988","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2005.10.037","article-title":"Growth inhibition, drug load, and degradation studies of gelatin\/methotrexate conjugates","volume":"308","author":"Ofner","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2009.06.026","article-title":"Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate","volume":"380","author":"Paliwal","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0215","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/jps.20572","article-title":"Gelatin-methotrexate conjugate microspheres as a potential drug delivery system","volume":"95","author":"Pica","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0220","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1083\/jcb.137.6.1445","article-title":"The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix","volume":"137","author":"Pilcher","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0225","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11912-003-0098-3","article-title":"Novel antifolate drugs","volume":"5","author":"Purcell","year":"2003","journal-title":"Curr Oncol. Rep."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0230","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1166\/jnn.2006.457","article-title":"Methotrexate loaded solid lipid nanoparticles (SLN) for effective treatment of carcinoma","volume":"6","author":"Ruckmani","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2009.07765.x","article-title":"Advances in individual prediction of methotrexate toxicity: a review","volume":"146","author":"Schmiegelow","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0240","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0031-6865(97)00013-7","article-title":"In vitro characterization of methotrexate loaded poly(lactic-co-glycolic) acid microspheres and antitumor efficacy in Sarcoma-180 mice bearing tumor","volume":"72","author":"Singh","year":"1997","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0245","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejpb.2010.06.014","article-title":"Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel","volume":"76","author":"Singka","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0031-6865(96)00003-9","article-title":"Influence of counter ions on the skin permeation of methotrexate from water\u2013oil microemulsions","volume":"71","author":"Trotta","year":"1996","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2003.10.006","article-title":"Deformable liposomes for dermal administration of methotrexate","volume":"270","author":"Trotta","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0260","doi-asserted-by":"crossref","first-page":"13894","DOI":"10.1038\/srep13894","article-title":"Development and characterization of a novel in vitro progression model for UVB-induced skin carcinogenesis","volume":"5","author":"Tyagi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.colsurfb.2017.01.019","article-title":"Mechanism of drug release from silica-gelatin aerogel\u2014relationship between matrix structure and release kinetics","volume":"152","author":"Veres","year":"2017","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jnoncrysol.2017.07.016","article-title":"Biocompatible silica-gelatin hybrid aerogels covalently labeled with fluorescein","volume":"473","author":"Veres","year":"2017","journal-title":"J. Non-Cryst. Solids"},{"key":"10.1016\/j.ijpharm.2019.01.024_b0275","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijpharm.2015.10.045","article-title":"Hybrid aerogel preparations as drug delivery matrices for low water-solubility drugs","volume":"496","author":"Veres","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0280","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s002800050821","article-title":"Pharmacokinetics, antifolate activity and tissue distribution of PT523 in SCC VII tumor-bearing mice","volume":"42","author":"Wright","year":"1998","journal-title":"Cancer. Chemother. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0285","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1016\/j.bmcl.2010.07.024","article-title":"Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells","volume":"20","author":"Wu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0290","doi-asserted-by":"crossref","first-page":"17049","DOI":"10.1038\/cddiscovery.2017.49","article-title":"Tumor cell senescence response produces aggressive variants","volume":"3","author":"Yang","year":"2017","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ijpharm.2019.01.024_b0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2008.12.003","article-title":"Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes","volume":"370","author":"Zhu","year":"2009","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319300596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319300596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:36:27Z","timestamp":1759916187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517319300596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":59,"alternative-id":["S0378517319300596"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled release of methotrexate from functionalized silica-gelatin aerogel microparticles applied against tumor cell growth","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}